Latest Options News

Omega Oil and Gas reports strong appraisal progress at its Canyon Project, highlighting premium light crude oil and multiple stacked pay zones, supported by a robust $15.1 million pro forma cash position.

MedAdvisor reports a significant revenue decline in FY25 amid US program delays but strengthens its balance sheet through a capital raise and ANZ business sale. The company signals a strategic pivot with potential US business divestment on the horizon.

Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.

Core Energy Minerals has initiated its first aircore drilling program at the Cummins Uranium Project in South Australia, while confirming uranium mineralisation in Brazil and refinancing its convertible notes to support ongoing exploration.

Sunshine Metals Limited reported a cautious quarterly cash flow with A$1.9 million in cash and 1.4 quarters of funding runway, highlighting the discretionary nature of its exploration activities and plans to secure further financing.

IRIS Metals has raised $4.267 million through a share placement to fund lithium exploration and development in South Dakota, aiming for a feasibility study completion by early 2026.

Cobre Limited reports strong metallurgical results from its Botswana copper projects alongside a successful AU$1.68 million capital raising, setting the stage for upcoming resource estimates and environmental approvals.

Rokeby Resources has completed its acquisition of Stunalara Metals, securing promising gold-copper-antimony tenements, and commenced a maiden drilling campaign at the Hurricane Project in Queensland.

Dotz Nano has partnered with CarbonCapture Inc. to scale its high-performance direct air capture sorbent, while raising AU$1.2 million to fund its DotzEarth project amid ongoing funding timing challenges.

Blue Star Helium has raised A$4.5 million through a strategic institutional placement to fund the final stages of its Galactica helium project, aiming for production by late 2025.

AMCIL Limited reported a net profit of $6.7 million for FY2025, down from $7.5 million the previous year, and announced a fully franked total dividend of 6.5 cents per share, boosted by a special capital gains payout.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.